Jennifer A. Sealey-Voyksner
Chief Tech/Sci/R&D Officer at ENTERO THERAPEUTICS, INC.
Profile
Jennifer A.
Sealey-Voyksner is the founder of ImmunogenX, Inc., a company founded in 2013.
She held the title of Director & Chief Scientific Officer from 2013 to 2024.
Currently, Dr. Sealey-Voyksner is the Vice President-Research & Development at First Wave Biopharma, Inc., starting in 2024.
Jennifer A. Sealey-Voyksner active positions
| Companies | Position | Start |
|---|---|---|
| ENTERO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2024-03-12 |
Former positions of Jennifer A. Sealey-Voyksner
| Companies | Position | End |
|---|---|---|
ImmunogenX LLC
 ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Founder | 2024-03-12 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ENTERO THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
ImmunogenX LLC
ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Health Technology |
- Stock Market
- Insiders
- Jennifer A. Sealey-Voyksner
